Does spinal dexmedetomidine aggravate hypotension after tourniquet deflation?
Not Applicable
Completed
- Conditions
- tourniquet hypotension
- Registration Number
- PACTR201703002085343
- Lead Sponsor
- Mansoura aculty of medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
ASA ¿ ¿ II.
Patients scheduled for elective knee arthroscopy under spinal anesthesia
Exclusion Criteria
¿Increased intracranial pressure.
¿Hemorrhagic diathesis.
¿Infection at the puncture site.
¿Neurological disorder.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link spinal dexmedetomidine to hypotension during tourniquet deflation?
How does spinal dexmedetomidine compare to traditional vasopressors in managing tourniquet-induced hypotension?
Are there specific biomarkers that predict susceptibility to hypotension when using spinal dexmedetomidine with tourniquets?
What are the potential adverse events associated with spinal dexmedetomidine administration in orthopedic surgery settings?
What combination therapies could mitigate hypotension risks while maintaining the benefits of spinal dexmedetomidine in tourniquet use?